InVivoMAb Anti-Influenza A virus(strain A/Brevig Mission/1/1918 H1N1) (strain A/South Carolina/1/1918 H1N1)) HA/Hemagglutinin Antibody (Iv0149) (VK515040)

Name: InVivoMAb Anti-Influenza A virus(strain A/Brevig Mission/1/1918 H1N1) (strain A/South Carolina/1/1918 H1N1)) HA/Hemagglutinin Antibody (Iv0149)
Brand: abinScience
SKU: VK515040
Price: 370 USD
Availability: InStock

Datasheet Share product Copy info

Price(USD):

Spec:

100ug
1mg

Number:

Get quote

Overview
Images
References
Datasheet
SDS

Overview

Catalog No.	VK515040
Description	InVivoMAb Anti-Influenza A virus HA/Hemagglutinin Antibody (Iv0149) [Iv0149] (VK515040) is a human monoclonal antibody detecting Hemagglutinin in Blocking, ELISA.
Species reactivity	Influenza A virus (strain A/Brevig Mission/1/1918 H1N1) (Influenza A virus (strain A/South Carolina/1/1918 H1N1))
Applications	Blocking, ELISA
Host species	Human
Isotype	IgG1, kappa
Clone ID	Iv0149
Clonality	Monoclonal
Target	Hemagglutinin, Hemagglutinin HA1 chain, Hemagglutinin HA2 chain, HA
Endotoxin level	Please contact with the lab for this information.
Purity	>95% as determined by SDS-PAGE.
Purification	Protein A/G purified from cell culture supernatant.
Accession	Q9WFX3
Form	Liquid
Storage buffer	0.01M PBS pH 7.4 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
Stability and Storage	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Background	Hemagglutinin (HA) is a ~62 kDa protein. Binds to sialic acid-containing receptors on the cell surface, bringing about the attachment of the virus particle to the cell. This attachment induces virion internalization either through clathrin-dependent endocytosis or through clathrin- and caveolin-independent pathway. Plays a major role in the determination of host range restriction and virulence. Class I viral fusion protein. Responsible for penetration of the virus into the cell cytoplasm by mediating the fusion of the membrane of the endocytosed virus particle with the endosomal membrane.
Note	For research use only. Not suitable for clinical or therapeutic use.